Biomaxima SA (DE:944)
FRANKFURT:944
944 Stock Chart & Stats
€2.56
-€0.07(-2.92%)
At close: 4:00 PM EST
€2.56
-€0.07(-2.92%)
Day’s Range― - ―
52-Week Range€1.86 - €3.38
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€9.38M
Enterprise Value€56.29M
Total Cash (Recent Filing)€423.00K
Total Debt (Recent Filing)€16.12M
Price to Earnings (P/E)―
Beta0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding4,193,118
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-5.97
Price to Book (P/B)1.05
Price to Sales (P/S)0.83
P/FCF Ratio37.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.61
Revenue Forecast (FY)€19.09M
944 FAQ
What was Biomaxima SA’s price range in the past 12 months?
Biomaxima SA lowest stock price was €1.86 and its highest was €3.38 in the past 12 months.
What is Biomaxima SA’s market cap?
Biomaxima SA’s market cap is €9.38M.
When is Biomaxima SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biomaxima SA’s earnings last quarter?
Currently, no data Available
Is Biomaxima SA overvalued?
According to Wall Street analysts Biomaxima SA’s price is currently Overvalued.
Does Biomaxima SA pay dividends?
Biomaxima SA does not currently pay dividends.
What is Biomaxima SA’s EPS estimate?
Biomaxima SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biomaxima SA have?
Biomaxima SA has 4,193,118 shares outstanding.
What happened to Biomaxima SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biomaxima SA?
Currently, no hedge funds are holding shares in DE:944
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biomaxima SA
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form. In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, autoclave equipment, and pliers and scissors. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.
Technical Analysis
Genomtec SA
―
Pure Biologics SA
―
Scope Fluidics SA
―
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
―
Mabion SA
―